Tag Archives: startups

Why Do So Many Investors Come To RESI? It’s Not Only To Meet Startups

30 Nov

By Cole Bunn, Senior Research Analyst, LSN

cole-wp

Life Science Nation (LSN) brought the Redefining Early Stage Investments (RESI) conference to life four years ago with the vision of creating a circuit of events focused on bringing together life science entrepreneurs and early-stage investors, from a wide variety of categories, based on mutual fit. One of the most prominent themes we’ve witnessed, after 15 RESI conferences in cities across North America, is the complexity and evolution of the early-stage healthcare ecosystem. The variety of capital sources, strategic partners and other critical stakeholders in the industry has created an environment where investment groups/firms find tremendous value in working together to finance, scale and exit companies.

Investors are primarily drawn to RESI by the large number of top tier startups that attend, but RESI has become much more than a place for investors to find startups and vice versa. While the bulk of the meetings that take place at RESI are between investors and entrepreneurs, RESI also provides a venue for investors to find the newest capital sources, complimentary co-investors and foster relationships with a range of otherwise strategic and exit partners.

We took a look at the partnering meeting data, and discovered that in terms of who meets with whom at RESI conferences, investor-to-investor partnering meetings represent the third largest category, after investor-to-startup meetings and startup-to-service provider meetings. Driven by the unique nature of the early-stage healthcare landscape, LSN’s dedication to bringing in a diverse pool of capital providers makes RESI a must-attend event for all investors and entrepreneurs alike.

We asked some regular attendees their thoughts on RESI’s capacity to help investors connect, and here’s what they said:

“RESI provides a dynamic and fast-paced setting for strategic investors, venture capitalists and entrepreneurs to explore the latest innovations that will disrupt conventional healthcare and redefine the means by which we enable health and wellness in our communities.  As strategic investors, we are particularly interested in RESI to find opportunities to build more patient-centric care models, pilot scalable and efficient delivery models and identify business opportunities to successfully tackle the ‘big’ challenges in healthcare.”
Eric Louie, CMO, Healthbox Global Partners

“I have attended multiple RESIs over the years in SF, NYC and Toronto.  Each has given me a unique perspective on the ecosystem of the area and allowed me to connect with like-minded co-investors and strategic partners.  I will definitely be at the RESI in SF this January.”
Sam Ifergan, President & CEO, iGan Partners

“The RESI conference platform is a highly productive forum for me to engage with both early-stage entrepreneurs and investors. The 30-minute format allows for just enough time to gain a high level understanding of an opportunity or an investors profile. I attend several each year and recommend highly when speaking with both founders and co-investors.”
Sean Kearney, Managing Director, Fosun Group

Qualified investment firms can receive up to two complimentary passes to attend the upcoming RESI conference in San Francisco on January 9, 2018. The previous RESI @ JPM event hit capacity two weeks prior to the date of the conference. Please reach out to research@lifesciencenation.com to request registration for the event and take advantage of the RESI partnering system to secure meetings and get the most out of your Tuesday during JPM week.

 

RESI Innovation Challenge: LSN’s Scientific Review Team Selects 30 Top Life Science Startups

1 Jun

By Christine A. Wu, Senior Research Analyst, LSN

chrsitine

We are pleased to announce our thirty finalists to compete in the Innovation Challenge at Life Science Nation’s (LSN) first-ever RESI in San Diego. From a pool of approximately 100 applicants, the LSN Scientific Review Team has selected a diverse group of life science startups: three healthcare IT, three diagnostic, thirteen therapeutic, and eleven medical device companies.  These startups will showcase themselves in the exhibit hall display spaces at RESI on June 19th. The quality of these companies should not go unnoticed, as we have seen nearly 50% of Innovation Challenge finalists from previous RESI’s receive funding within one year of their debut.

From personalized cancer immunotherapies to digital pathology imaging, these companies cover a diverse range of life science technologies. Coming from all over the world, the companies will be competing based on scientific merit and investment potential, pitching to RESI attendees and showcasing their innovations. Be sure to catch them and make your “investments” at the RESI Exhibition Hall in just a couple weeks!

Therapeutic
 
Diagnostic
Medical Device
 
Healthcare IT
 

Key Stakeholders Share the Value of RESI for Early Stage Investors and Startups

27 Apr

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

In San Diego on June 19th, the Redefining Early Stage Investments (RESI) Conference will bring a new, early stage focused discussion venue for startups and investors who are visiting BIO week and want more opportunities to connect. What makes RESI different? At our last event, RESI on MaRS in Toronto, we asked our key stakeholders this question and here’s what they told us.

Ying Tam – Head of Digital Health – MaRS Discovery District

“All the research says that one of the critical elements for an entrepreneur ecosystem, especially in health, is funding and investment. It takes a long time to nurture a health company, to get it to market and commercialization and scale. So, investment is critical for the development of a startup in health. RESI brings in a whole set of investors from across North America and across the world.”

Rebecca Yu – Head of JLABS @ TorontoJohnson & Johnson Innovation JLABS

“RESI attracts many repeat attendees, and that speaks to me that there’s a story, there’s something here. There’s great stuff happening here for entrepreneurs. There’s early stage companies from across Canada, from pharmaceuticals to medical devices to consumer health, and of course there’s a big digital health and AI presence here in Toronto. That’s why JLABS and J&J are here. We play in all the sectors, we partner with different groups within this ecosystem, and we see LSN/RESI as a key partner as well, to bring investors to this ecosystem.”

Richard Soll – Senior Vice President, International Discovery Service Unit – WuXi AppTec

“The RESI conference is an opportunity to help out these early stage companies such that they can achieve inflection points. If I can identify companies early, then I might become a vendor of choice for them. Getting in early becomes an important objective for me. When I come to a conference like RESI, I come to these early stage companies who are really looking for partnering with investors here, but also get an opportunity to introduce WuXi to them as well.”

RESI attendees can book up to 16 meetings with investors in one day, right at the start of BIO Week. If you want to take this opportunity to start your BIO with a bang, register now.

%d bloggers like this: